Franklin Resources’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
+5,769,230
| New | +$13.1M | ﹤0.01% | 1046 |
|
|
2024
Q1 | – | Sell |
-26,838
| Closed | -$41.6K | – | 2883 |
|
|
2023
Q4 | $41.6K | Hold |
26,838
| – | – | ﹤0.01% | 2524 |
|
|
2023
Q3 | $34.6K | Sell |
26,838
-7,246
| -21% | -$9.35K | ﹤0.01% | 2550 |
|
|
2023
Q2 | $58.6K | Hold |
34,084
| – | – | ﹤0.01% | 2590 |
|
|
2023
Q1 | $51.5K | Hold |
34,084
| – | – | ﹤0.01% | 2180 |
|
|
2022
Q4 | $54.5K | Hold |
34,084
| – | – | ﹤0.01% | 2203 |
|
|
2022
Q3 | $49K | Hold |
34,084
| – | – | ﹤0.01% | 2198 |
|
|
2022
Q2 | $62K | Sell |
34,084
-16,595
| -33% | -$30.2K | ﹤0.01% | 2210 |
|
|
2022
Q1 | $135K | Hold |
50,679
| – | – | ﹤0.01% | 2241 |
|
|
2021
Q4 | $219K | Sell |
50,679
-121
| -0.2% | -$523 | ﹤0.01% | 2202 |
|
|
2021
Q3 | $259K | Buy |
+50,800
| New | +$259K | ﹤0.01% | 2132 |
|
|
2018
Q4 | – | Sell |
-333,576
| Closed | -$6.17M | – | 1481 |
|
|
2018
Q3 | $6.17M | Hold |
333,576
| – | – | ﹤0.01% | 1017 |
|
|
2018
Q2 | $7.63M | Buy |
333,576
+76
| +0% | +$1.74K | ﹤0.01% | 969 |
|
|
2018
Q1 | $9.49M | Hold |
333,500
| – | – | ﹤0.01% | 930 |
|
|
2017
Q4 | $7.04M | Hold |
333,500
| – | – | ﹤0.01% | 1015 |
|
|
2017
Q3 | $6.06M | Hold |
333,500
| – | – | ﹤0.01% | 1034 |
|
|
2017
Q2 | $5.17M | Hold |
333,500
| – | – | ﹤0.01% | 1077 |
|
|
2017
Q1 | $5.76M | Hold |
333,500
| – | – | ﹤0.01% | 1081 |
|
|
2016
Q4 | $3.67M | Hold |
333,500
| – | – | ﹤0.01% | 1137 |
|
|
2016
Q3 | $5.23M | Hold |
333,500
| – | – | ﹤0.01% | 1099 |
|
|
2016
Q2 | $3.41M | Buy |
333,500
+33,500
| +11% | +$342K | ﹤0.01% | 1166 |
|
|
2016
Q1 | $3.87M | Hold |
300,000
| – | – | ﹤0.01% | 1147 |
|
|
2015
Q4 | $6.26M | Buy |
+300,000
| New | +$6.26M | ﹤0.01% | 1092 |
|